Why the study?
Does glycogen phosphorylase BB (GPBB) measurement improve the early diagnosis of acute coronary syndrome?
Does glycogen phosphorylase BB (GPBB) measurement improve the early diagnosis of acute coronary syndrome?
GPBB measurement in the first hours of ACS onset provides high diagnostic efficacy and could be optimally combined with troponin testing for early diagnosis.
May support GPBB for early ACS diagnosis independent of troponin; leaves open prospective validation before clinical adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Stejskal et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: